He Dou
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
-
- Breast Cancer Treatment Studies 4
- MicroRNA in disease regulation 1
- Cancer, Hypoxia, and Metabolism 1
- Oncology 6
- Cancer Risks and Factors 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Min Xiao (10 shared papers)Shanshan Yang (2 shared papers)Sifan Zhang (1 shared paper)Yingpu Li (1 shared paper)Xueying Wang (1 shared paper)Yu Xi (1 shared paper)Zhiren Zhang (1 shared paper)Zhennan Yuan (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Translational Oncology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Diagnostic Pathology (1 paper)Experimental Cell Research (1 paper)
- Partner nations
- China
In The Last Decade
He Dou
7 papers receiving 646 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 207
- Oncology 218
- Immunology and Allergy 40
- Immunology 126
- Cell Biology 73
Countries citing papers authored by He Dou
This map shows the geographic impact of He Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Dou more than expected).
Fields of papers citing papers by He Dou
This network shows the impact of papers produced by He Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Dou. The network helps show where He Dou may publish in the future.
Co-authors
The 22 scholars most cited alongside He Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments Hit paper breakdown → | 2023 | 478 |
| 2 | 2020 | 128 | |
| 3 | 2023 | 18 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2025 | 0 | |
| 10 | 2024 | 0 |
About He Dou
He Dou is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Obstetrics and Gynecology and Dermatology, having authored 10 papers that have together received 646 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Risks and Factors (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer and Skin Lesions (1 paper), MicroRNA in disease regulation (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (207 citations), Oncology (218 citations), Immunology and Allergy (40 citations), Immunology (126 citations) and Cell Biology (73 citations). He Dou has collaborated with scholars based in China. Frequent co-authors include Min Xiao, Shanshan Yang, Sifan Zhang, Yingpu Li, Xueying Wang, Yu Xi, Zhiren Zhang, Zhennan Yuan, Yuanxi Huang and Feng Liu. Their work appears in journals such as Frontiers in Oncology, Translational Oncology, Journal of Cancer Research and Clinical Oncology, Diagnostic Pathology and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.